These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32510581)

  • 1. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
    Wang Z; Wang Z; Xiong G
    Int J Gynaecol Obstet; 2020 Sep; 150(3):312-317. PubMed ID: 32510581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study.
    Wei L; Gao X; Chen S; Zeng W; Wu J; Lin X; Zhang H; Mwamaka Sharifu L; Chen L; Feng L; Wang S
    J Med Internet Res; 2020 Aug; 22(8):e19642. PubMed ID: 32750000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
    DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
    Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.
    Mohr-Sasson A; Chayo J; Bart Y; Meyer R; Sivan E; Mazaki-Tovi S; Yinon Y
    Arch Gynecol Obstet; 2020 Sep; 302(3):629-634. PubMed ID: 32572616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Analysis of Clinical Characteristics and Neonatal Outcomes of Pregnant Women with SARS-COV-2 Infection.
    Chen Y; Pang XL; Ding WP; Peng XC; Yang J; Zhou Y
    Curr Med Sci; 2021 Apr; 41(2):306-311. PubMed ID: 33877546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women.
    Vizheh M; Muhidin S; Aghajani F; Maleki Z; Bagheri F; Hosamirudsari H; Aleyasin A; Tehranian A
    Int J Gynaecol Obstet; 2021 Jun; 153(3):462-468. PubMed ID: 33829492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montréal.
    Trahan MJ; Mitric C; Malhamé I; Abenhaim HA
    J Obstet Gynaecol Can; 2021 May; 43(5):571-575. PubMed ID: 33358711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
    Zambrano LD; Ellington S; Strid P; Galang RR; Oduyebo T; Tong VT; Woodworth KR; Nahabedian JF; Azziz-Baumgartner E; Gilboa SM; Meaney-Delman D;
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(44):1641-1647. PubMed ID: 33151921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review.
    Vakili S; Savardashtaki A; Jamalnia S; Tabrizi R; Nematollahi MH; Jafarinia M; Akbari H
    Arch Med Res; 2020 Oct; 51(7):603-607. PubMed ID: 32571605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of COVID-19 pneumonia in pregnant versus matched non-pregnant women: radiologic, laboratory, and clinical perspectives.
    Raoufi M; Hojabri M; Samiei Nasr D; Najafiarab H; Salahi-Niri A; Ebrahimi N; Ariana S; Khodabandeh H; Salarian S; Looha MA; Pourhoseingholi MA; Safavi-Naini SAA
    Sci Rep; 2024 Sep; 14(1):22609. PubMed ID: 39349664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A considerable asymptomatic proportion and thromboembolism risk of pregnant women with COVID-19 infection in Wuhan, China.
    Wang Y; Liang X; Wang H; Li L; Xiong G; Mi L
    J Perinat Med; 2021 Feb; 49(2):237-240. PubMed ID: 33470960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 17. Poor maternal-neonatal outcomes in pregnant patients with confirmed SARS-Cov-2 infection: analysis of 145 cases.
    Di Guardo F; Di Grazia FM; Di Gregorio LM; Zambrotta E; Carrara G; Gulino FA; Tuscano A; Palumbo M
    Arch Gynecol Obstet; 2021 Jun; 303(6):1483-1488. PubMed ID: 33389111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
    Fassett MJ; Lurvey LD; Yasumura L; Nguyen M; Colli JJ; Volodarskiy M; Gullett JC; Braun D; Fong A; Trivedi N; Bruxvoort K; Chiu V; Getahun D
    Am J Perinatol; 2020 Sep; 37(11):1110-1114. PubMed ID: 32620022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia.
    Wu X; Sun R; Chen J; Xie Y; Zhang S; Wang X
    Int J Gynaecol Obstet; 2020 Jul; 150(1):58-63. PubMed ID: 32270479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine screening for SARS CoV-2 in unselected pregnant women at delivery.
    Díaz-Corvillón P; Mönckeberg M; Barros A; Illanes SE; Soldati A; Nien JK; Schepeler M; Caradeux J
    PLoS One; 2020; 15(9):e0239887. PubMed ID: 32991621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.